The National Institutes of Health released a landmark atlas of senescent cells that could guide development of therapies for age-related diseases, according to biomedical reporting. Senescent cells stop dividing but remain metabolically active, secreting factors that can damage neighboring tissue.
Mapping where these cells accumulate across organs provides a reference for researchers designing drugs to clear or modulate them. Senolytic therapies targeting aging cells have shown promise in animal studies for conditions such as frailty and osteoarthritis.
The atlas represents one of the first large-scale NIH efforts to catalog senescence at comprehensive resolution. The summary did not detail cell types covered or accompanying genomic datasets.
Translating atlas insights into human treatments requires clinical trials measuring safety and efficacy. Regulatory pathways for aging-related indications remain evolving.
Researchers worldwide can access the resource for hypothesis generation.
NIH’s first large-scale atlas of senescent cells maps where aging-related cells accumulate across tissues. Researchers expect the reference to inform anti-aging therapy development, while the summary did not list organs covered or companion genomic datasets released.
Senescent cell mapping at scale could steer future anti-aging therapy research, NIH said in releasing the atlas.
Senolytic drug developers can now cross-reference the atlas when selecting tissue targets for trials.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.nih.gov/news-events